Search
Entera Bio Ltd
ENTXAdd to Watchlist
1.660USD
-0.030-1.78%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
77.39MMarket Cap
LossP/E TTM
More Details of Entera Bio Ltd Company
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Entera Bio Ltd Info
Ticker SymbolENTX
Company nameEntera Bio Ltd
IPO dateJun 28, 2018
CEOToledano (Miranda Jayne)
Number of employees18
Security typeOrdinary Share
Fiscal year-endJun 28
AddressHadassah / Jerusalem Bio
CityJERUSALEM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code9112002
Phone97225327151
Websitehttps://enterabio.com/
Ticker SymbolENTX
IPO dateJun 28, 2018
CEOToledano (Miranda Jayne)
Company Executives of Entera Bio Ltd
Name
Name/Position
Position
Shareholding
Change
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
426.57K
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
Dr. Hillel Galitzer
Dr. Hillel Galitzer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Roger J. Garceau, M.D.
Dr. Roger J. Garceau, M.D.
Director
Director
--
--
Dr. Arthur C. Santora
Dr. Arthur C. Santora
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Dana Yaacov-Garbeli
Ms. Dana Yaacov-Garbeli
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
426.57K
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
188.09K
-0.00%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
98.48K
--
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
59.42K
-30.29%
FAQs
Who are the top five shareholders of Entera Bio Ltd?
The top five shareholders of Entera Bio Ltd are: Ms. Miranda Jayne Toledano
How many institutions hold shares of Entera Bio Ltd (ENTX)?
As of 2026Q1, 34 institutions hold shares of Entera Bio Ltd, with a combined market value of approximately 9.31M, accounting for 17.10% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -4212.00.